Comparable observations were made by Stagni et al., who investigated 46 metastatic BRAF-mutant melanoma patients before treatment with BRAF inhibitors; 50% displayed BRAF gains, mostly related to chromosome 7 gain. The gene discussed is BRAF; the disease is melanoma.